billiontoone.comHealthcare / BioTech & PharmaFounded: 2016Funding to Date: $1.03B
BillionToOne is a molecular counter platform designed to accurately count DNA molecules to the single-count level. With a mission to detect disorders such as cystic fibrosis and sickle-cell disease, the company optimizes the signal-to-noise ratio through blood testing. The platform specializes in both prenatal and oncology divisions. BillionToOne was founded by David Tsao, Oguzhan Atay, and Sukrit Silas in 2016 and is headquartered in San Francisco, CA.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
06/21/2024 | Series D | $130.47MM | $xx.xx | $1.25B | Adam Street Partners, Baillie Gifford, Civilization Ventures, Fifty Years, Hummingbird Ventures, Libertus Capital, Neuberger Berman, Premji Invest | |
Price per Share
$xx.xx
Shares Outstanding
4,656,233
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.2x
Conversion Ratio
1.2x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Adam Street Partners, Baillie Gifford, Civilization Ventures, Fifty Years, Hummingbird Ventures, Libertus Capital, Neuberger Berman, Premji Invest
|
||||||
12/15/2022 | Series C-1 | $33.87MM | $xx.xx | $813.63MM | Adams Street Partners, Baillie Gifford, Fifty Years Vc, Hummingbird Ventures, Libertus Capital, Neotribe Ventures, Norwest Venture Partners, Time Bioventures | |
Price per Share
$xx.xx
Shares Outstanding
1,726,823
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Adams Street Partners, Baillie Gifford, Fifty Years Vc, Hummingbird Ventures, Libertus Capital, Neotribe Ventures, Norwest Venture Partners, Time Bioventures
|
||||||
03/30/2022 | Series C | $155MM | $xx.xx | $973.82MM | Adams Street Partners, Baillie Gifford, Civilization Ventures, Fifty Years Vc, Hummingbird Ventures, Libertus Capital, Neotribe Ventures, Norwest Venture Partners, Pacific 8 Ventures, Time Bioventures | |
Price per Share
$xx.xx
Shares Outstanding
6,079,919
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Adams Street Partners, Baillie Gifford, Civilization Ventures, Fifty Years Vc, Hummingbird Ventures, Libertus Capital, Neotribe Ventures, Norwest Venture Partners, Pacific 8 Ventures, Time Bioventures
|
||||||
07/12/2021 | Series B-1 | $55MM | $xx.xx | $341.88MM | Four Rivers Group, Hummingbird Ventures, Libertus Capital, Neotribe Ventures, Norwest Venture Partners, Y Combinator | |
Price per Share
$xx.xx
Shares Outstanding
5,182,287
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Four Rivers Group, Hummingbird Ventures, Libertus Capital, Neotribe Ventures, Norwest Venture Partners, Y Combinator
|
||||||
03/10/2020 | Series B-2 | $16.02MM | $xx.xx | $148.58MM | 500 Startups, Civilization Ventures, Hof Capital, Hummingbird Ventures, Libertus Capital, Neotribe Ventures, Pacific 8 Ventures, Y Combinator | |
Price per Share
$xx.xx
Shares Outstanding
2,566,902
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
500 Startups, Civilization Ventures, Hof Capital, Hummingbird Ventures, Libertus Capital, Neotribe Ventures, Pacific 8 Ventures, Y Combinator
|
||||||
03/28/2019 | Series A-6 | $15.02MM | $xx.xx | $60.38MM | 500 Startups, Civilization Ventures, Hof Capital, Hummingbird Ventures, Libertus Capital, Neotribe Ventures, Pacific 8 Ventures, Y Combinator | |
Price per Share
$xx.xx
Shares Outstanding
5,805,861
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
500 Startups, Civilization Ventures, Hof Capital, Hummingbird Ventures, Libertus Capital, Neotribe Ventures, Pacific 8 Ventures, Y Combinator
|
||||||
08/22/2017 | Series A-1 | $539,994.97 | $xx.xx | $45.29MM | Friale, Newdo Venture, Pacific 8 Ventures, Uphonest Capital, Y Combinator | |
Price per Share
$xx.xx
Shares Outstanding
1,349,650
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Friale, Newdo Venture, Pacific 8 Ventures, Uphonest Capital, Y Combinator
|
||||||
08/22/2017 | Series A-2 | $909,995.44 | $xx.xx | $45.29MM | Friale, Newdo Venture, Pacific 8 Ventures, Uphonest Capital, Y Combinator | |
Price per Share
$xx.xx
Shares Outstanding
1,137,210
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Friale, Newdo Venture, Pacific 8 Ventures, Uphonest Capital, Y Combinator
|
||||||
08/22/2017 | Series A-5 | $99,999.84 | $xx.xx | $45.29MM | Friale, Newdo Venture, Pacific 8 Ventures, Uphonest Capital, Y Combinator | |
Price per Share
$xx.xx
Shares Outstanding
114,613
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Friale, Newdo Venture, Pacific 8 Ventures, Uphonest Capital, Y Combinator
|
||||||
08/22/2017 | Series A-3 | $899,999.92 | $xx.xx | $45.29MM | Friale, Newdo Venture, Pacific 8 Ventures, Uphonest Capital, Y Combinator | |
Price per Share
$xx.xx
Shares Outstanding
899,730
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Friale, Newdo Venture, Pacific 8 Ventures, Uphonest Capital, Y Combinator
|
||||||
08/22/2017 | Series A-4 | $49,999.52 | $xx.xx | $45.29MM | Friale, Newdo Venture, Pacific 8 Ventures, Uphonest Capital, Y Combinator | |
Price per Share
$xx.xx
Shares Outstanding
25,761
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Friale, Newdo Venture, Pacific 8 Ventures, Uphonest Capital, Y Combinator
|